|
- 2016
慢性阻塞性肺病诱导轻度认知功能障碍的回顾性队列研究
|
Abstract:
摘要:目的 近期研究发现慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)患者较多合并轻度认知功能障碍(mild cognitive impairment, MCI)。本文拟通过临床队列研究来探明COPD是否导致MCI的发生。方法 2002年1月至2003年12月,于西安交通大学第一附属医院门诊电子数据库中随机挑选850例认知功能正常的COPD研究人群,年龄在70~90岁之间。首次检查确定基线后,每15个月随访一次,接受症状问询、神经生理检测和心理检测。COPD由呼吸内科医师确诊。使用Cox比例风险模型分析MCI的危险因素。结果 本研究随访时间3.5~6年,中位随访期为5.5年。850例受检人群中,265例在随访期出现了MCI。COPD显著增加了轻度认知功能障碍(HR 2.12;95% CI:1.36~3.18;P<0.01)以及其非记忆缺失亚型(non-amnestic mild cognitive impairment, na-MCI)的发生风险(HR 2.65;95% CI:1.86~3.89;P<0.01)。Cox多因素分析发现COPD不是MCI总体和轻度认知功能障碍的记忆缺失亚型(amnestic mild cognitive impairment, a-MCI)发生的独立危险因素。本研究还发现对于长期患有COPD的患者,COPD严重程度与MCI(HR 2.52;95% CI:1.97~3.62;P<0.01)和na-MCI(HR 2.07;95% CI:1.67~2.83;P<0.01)发生率呈正相关关系。结论 COPD明显增加了中老年人群MCI(尤其是na-MCI)的发生率,而且COPD严重程度与MCI发生率呈正相关关系。COPD是MCI发生的危险因素,早期干预COPD可能预防或延缓MCI的发生或进展。
ABSTRACT: Objective Cross-sectional relationship between chronic obstructive pulmonary disease (COPD) and mild cognitive impairment (MCI) has been found according to recent literature. The present study intends to explore whether COPD is an increased risk for MCI. Methods We randomly selected 850 cognitively normal individuals aged 70-90 years from the outpatient department of the First Affiliated Hospital, Xi’an Jiaotong University, using the medical records linkage system. All the individuals were examined with an interview, neurological examination and neuropsychological testing at baseline and every 15 months thereafter. COPD was assessed as a risk factor for MCI and its subtype with the help of Cox proportional hazards models. Results During the follow-up (range: 3.5-6.0 years, median value: 5.5 years ), 265 out of 850 recruited individuals developed MCI. COPD led to an increased risk for MCI (HR 2.12; 95% CI: 1.36-3.18; P<0.01) and non-amnestic mild cognitive impairment (na-MCI) (HR 2.65; 95% CI: 1.86-3.89; P<0.01). Cox multi-factor analysis revealed that COPD was not an independent risk factor for MCI or a-MCI. We found a positive correlation of COPD severity with the incidence of MCI (HR 2.52; 95% CI: 1.97-3.62; P<0.01) and na-MCI (HR 2.07; 95% CI:1.67-2.83; P<0.01) in subjects with chronic COPD. Conclusion The data here support that COPD is a risk factor for MCI and the two are positively correlated. Early intervention is important in preventing or delaying the onset and progression of MCI
[1] | RABE KF, HURD S, ANZUETO A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary[J]. Am J Respir Crit Care Med, 2007, 176(6):532-555. |
[2] | HILL AT, BAYLEY D, STOCKLEY RA. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis[J]. Am J Respir Crit Care Med, 1999, 160(3):893-898. |
[3] | KEATINGS VM, COLLINS PD, SCOTT DM, et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma[J]. Am J Respir Crit Care Med, 1996, 153(2):530-534. |
[4] | ROBERTS RO, GEDA YE, KNOPMAN DS, et al. Association of C-reactive protein with mild cognitive impairment[J]. Alzheimer’s Dement, 2009, 5(5):398-405. |
[5] | ROBERTS RO, GEDA YE, KNOPMAN DS, et al. Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: a population-based Study[J]. Alzheimer Dis Assoc Disord, 2010, 24(1):11-18. |
[6] | MULLEROVA H, AGUSTI A, ERQOU S, et al. Cardiovascular comorbidity in COPD: Systematic literature review[J]. Chest, 2013, 144(4):1163-1178. |
[7] | ROBERS RO, GEDA YE, KNOPMAN DS, et al. Cardiac disease associated with increased risk of nonamnestic cognitive impairment: stronger effect on women[J]. JAMA Neurol, 2013, 70(3):374-382. |
[8] | LI J, HUANG Y, FEI GH. The evaluation of cognitive impairment and relevant factors in patients with chronic obstructive pulmonary disease[J]. Respiration, 2013, 85(2):98-105. |
[9] | VILLENEUVE S, PEPIN V, RAHAYEL S, et al. Mild cognitive impairment in moderate to severe COPD: a preliminary study[J]. Chest, 2012, 142(6):1516-1523. |
[10] | RUSANEN M, NGANDU T, LAATIKAINEN T, et al. Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study[J]. Curr Alzheimer Res, 2013, 10(5):549-555. |
[11] | ETTORRE E, CERRA E, MARIGLIANO B, et al. Role of cardiovascular risk factors (CRF) in the patients with mild cognitive impairment (MCI)[J]. Arch Gerontol Geriatr, 2012, 54(2):330-332. |
[12] | SCHOU L, OSTERAGAARD B, RASMUSSEN LS, et al. Cognitive dysfunction in patients with chronic obstructive pulmonary disease--a systematic review[J]. Respir Med, 2012,106(8):1071-1081. |
[13] | INCALZI RA, GEMMA A, MARRA C, et al. Chronic obstructive pulmonary disease. An original model of cognitive decline[J]. Am Rev Respir Dis, 1993, 148(2):418-424. |
[14] | BARNES PJ. Chronic obstructive pulmonary disease[J]. N Engl J Med, 2000, 343(4):269-280. |
[15] | YAFFE K, LINDQUIST K, PENNINX BW, et al. Inflammatory markers and cognition in well-functioning African-American and white elders[J]. Neurology, 2003,61(1):76-80. |
[16] | DODD JW, GETOV SV, JONES PW. Cognitive function in COPD[J]. Eur Respir J, 2010, 35(4):913-922. |
[17] | ORTAPAMUK H, NALDOKEN S. Brain perfusion abnormalities in chronic obstructive pulmonary disease: comparison with cognitive impairment[J]. Ann Nucl Med, 2006, 20(2):99-106. |
[18] | SINGH B, ARSAIK AK, MIELKE MM, et al. Chronic obstructive pulmonary disease is associated with mild cognitive impairment: the Mayo Clinic Study of Aging[J]. Mayo Clin Proc, 2013, 88(11):1222-1230. |
[19] | 冯芳,陈长香,陈桂芝. 老年慢性阻塞性肺疾病患者记忆障碍的病例对照研究[J]. 吉林大学学报(医学版), 2012, 38(2):324-327. |
[20] | WYSOCKI M, LUO X, SCHMEIDLER J, et al. Hypertension is associated with cognitive decline in elderly people at high risk for dementia[J]. Am J Geriatr Psychiatry, 2012, 20(2):179-187. |
[21] | DE LA TORRE JC. Critical threshold cerebral hypoperfusion causes Alzheimer’s disease?[J]. Acta Neuropathol, 1999, 98(1):1-8. |
[22] | STUSS DT, PETERKINI, GUZMAN DA, et al. Chronic obstructive pulmonary disease: effects of hypoxia on neurological and neuropsychological measures[J]. J Clin Exp Neuropsychol, 1997, 19(4):515-524. |
[23] | SCHRIJVERS EM, KOUDSTAAL PJ, HOFMAN A, et al. Plasma clusterin and the risk of Alzheimer disease[J]. JAMA, 2011, 305(13):1322-1326. |